Gavin Giovannoni (G Giovannoni)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 42

Top Topics

Clinical Practice

Platelet Rich Plasma

Stem Cell Transplantation

Multiple Sclerosis

Top Venues

Therapeutic advances in neurological disorders

Practical neurology

Neurology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ardra Shephard, Laura Kolaczkowski, Noreen Barker, Donna Nahal, Celia Oreja-Guevara, Saúl Reyes, Helen Gray, Hashem Salloukh, Gavin Giovannoni
Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals. Neurology and therapy 13 (4) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Ardra Shephard, Laura Kolaczkowski, Noreen Barker, Donna Nahal, Celia Oreja-Guevara, Saúl Reyes, Helen Gray, Hashem Salloukh, Gavin Giovannoni
Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals. Neurology and therapy (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Ardra Shephard, Laura Kolaczkowski, Noreen Barker, Donna Nahal, Celia Oreja-Guevara, Saúl Reyes, Helen Gray, Hashem Salloukh, Gavin Giovannoni
Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals. Neurology and therapy 13 (4) (2024)
James Blackstone, Thomas Williams, Jennifer M Nicholas, Ekaterina Bordea, Floriana De Angelis, Alessia Bianchi, Alberto Calvi, Anisha Doshi, Nevin John, Sean Apap Mangion, Charles Wade, Rachel Merry, Gil Barton, Dawn Lyle, Elisabeth Jarman, Don Mahad, Abdullah Shehu, Tarunya Arun, Gavin McDonnell, Ruth Geraldes, Matthew Craner, Charles Hillier, Jeban Ganesalingam, Leonora Fisniku, Jeremy Hobart, Cord Spilker, Neil Robertson, Seema Kalra, Stefano Pluchino, Sreedharan Harikrishnan, Miriam Mattoscio, Timothy Harrower, Carolyn Young, Martin Lee, Suresh Chhetri, Fayyaz Ahmed, David Rog, Eli Silber, Paul Gallagher, Martin Duddy, Agne Straukiene, Richard Nicholas, Claire Rice, Stuart J Nixon, Judy Beveridge, Annie Hawton, Susan Tebbs, Marie Braisher, Gavin Giovannoni, Olga Ciccarelli, John Greenwood, Alan J Thompson, Rachael Maree Hunter, Sue Pavitt, Owen Pearson, Nikos Evangelou, Basil Sharrack, Ian Galea, Siddharthan Chandran, Helen L Ford, Chris Frost, Jeremy Chataway
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ open 14 (9) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Ardra Shephard, Laura Kolaczkowski, Noreen Barker, Donna Nahal, Celia Oreja-Guevara, Saúl Reyes, Helen Gray, Hashem Salloukh, Gavin Giovannoni
Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals. Neurology and therapy 13 (4) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Ralf Gold, Michael Barnett, Andrew Chan, Huiyu Feng, Kazuo Fujihara, Gavin Giovannoni, Xavier Montalbán, Fu-Dong Shi, Mar Tintoré, Qun Xue, Chunsheng Yang, Hongyu Zhou
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method. Therapeutic advances in neurological disorders 16 (2023)
Irina Kalatskaya, Gavin Giovannoni, Thomas Leist, Joseph Cerra, Ursula Boschert, P Alexander Rolfe
Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment. Scientific reports 13 (1) (2023)
Celia Oreja-Guevara, Stanca Potra, Birgit Bauer, Diego Centonze, Maria-Paz Giambastiani, Gavin Giovannoni, Jϋrg Kesselring, Dawn Wendy Langdon, Sarah A Morrow, Jocelyne Nouvet-Gire, Maija Pontaga, Peter Rieckmann, Sven Schippling, Nektaria Alexandri, Jane Shanahan, Heidi Thompson, Pieter van Galen, Patrick Vermersch, David Yeandle
Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care. Advances in therapy (2023)
Alasdair J Coles, Anat Achiron, Anthony Traboulsee, Barry A Singer, Carlo Pozzilli, Celia Oreja-Guevara, Gavin Giovannoni, Giancarlo Comi, Mark S Freedman, Tjalf Ziemssen, Debora Shiota, Andreea M Rawlings, Alana T Wong, Magdalena Chirieac, Xavier Montalban
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study. Therapeutic advances in neurological disorders 16 (2023)
Irina Kalatskaya, Gavin Giovannoni, Thomas Leist, Joseph Cerra, Ursula Boschert, P Alexander Rolfe
Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment. Scientific reports 13 (1) (2023)
Irina Kalatskaya, Gavin Giovannoni, Thomas Leist, Joseph Cerra, Ursula Boschert, P Alexander Rolfe
Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment. Scientific reports 13 (1) (2023)
Kimberley Allen-Philbey, Stefania De Trane, Amy MacDougall, Ashok Adams, Lucia Bianchi, Thomas Campion, Gavin Giovannoni, Sharmilee Gnanapavan, David W Holden, Monica Marta, Joela Mathews, Benjamin P Turner, David Baker, Klaus Schmierer
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis. Therapeutic advances in neurological disorders 16 (2023)
Irina Kalatskaya, Gavin Giovannoni, Thomas Leist, Joseph Cerra, Ursula Boschert, P Alexander Rolfe
Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment. Scientific reports 13 (1) (2023)
Benjamin Meir Jacobs, Michelle Peter, Gavin Giovannoni, Alastair J Noyce, Huw R Morris, Chu-Yueh Guo
Towards a global view of multiple sclerosis genetics. Nature reviews. Neurology 18 (10) (2022)
Gavin Brittain, Alasdair J Coles, Gavin Giovannoni, Paolo Antonio Muraro, Jacqueline Palace, Jennifer Petrie, Elisa Roldan, Neil J Scolding, John A Snowden, Basil Sharrack
Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why? Practical neurology (2022)
Vanessa Beynon, Ilena C George, Colm Elliott, Douglas L Arnold, Jun Ke, Huaihou Chen, Li Zhu, Chunlei Ke, Gavin Giovannoni, Matthew Scaramozza, Nolan Campbell, Daniel P Bradley, Nathalie Franchimont, Arie Gafson, Shibeshih Belachew
Chronic lesion activity and disability progression in secondary progressive multiple sclerosis. BMJ neurology open 4 (1) (2022)
Gavin Giovannoni, Veronica Popescu, Jens Wuerfel, Kerstin Hellwig, Ellen Iacobaeus, Michael B Jensen, José Manuel García-Domínguez, Livia Sousa, Nicola De Rossi, Raymond Hupperts, Giuseppe Fenu, Benedetta Bodini, Hanna-Maija Kuusisto, Bruno Stankoff, Jan N Lycke, Laura Airas, Cristina Granziera, Antonio Scalfari
Smouldering multiple sclerosis: the 'real MS'. Therapeutic advances in neurological disorders 15 (2022)
Tjalf Ziemssen, Jo Vandercappellen, Valeria Jordan Mondragon, Gavin Giovannoni
MSProDiscuss™ Clinical Decision Support Tool for Identifying Multiple Sclerosis Progression. Journal of clinical medicine 11 (15) (2022)
Chu-Yueh Guo, Dylan R Rice, Marie Beatrice D'hooghe, Rachel Horne, Yvonne Learmonth, Farrah J Mateen, Claudia H Marck, Saúl Reyes, Mitzi Joi Williams, Gavin Giovannoni, Helen L Ford
Social determinants of health in multiple sclerosis. Nature reviews. Neurology 18 (12) (2022)
Gavin Giovannoni, Joela Mathews
Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis: A Clinician's Review. Neurology and therapy 11 (2) (2022)
Benjamin Meir Jacobs, Daniel Belete, Jonathan Bestwick, Cornelis Blauwendraat, Sara Bandres-Ciga, Karl Heilbron, Chu-Yueh Guo, Mike A Nalls, Andrew B Singleton, John Hardy, Gavin Giovannoni, Andrew John Lees, Anette-Eleonore Schrag, Alastair J Noyce
Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank. Journal of neurology, neurosurgery, and psychiatry 91 (10) (2021)
Ide Smets, Silvia Marino, Gavin Giovannoni
Amyloidoma mimicking multiple sclerosis. Practical neurology (2021)
Gavin Giovannoni, Giancarlo Comi, Kottil Rammohan, Peter Rieckmann, Fernando Dangond, Birgit Keller, Dominic Jack, Patrick Vermersch
Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies. Advances in therapy 38 (9) (2021)
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice. Therapeutic advances in neurological disorders 14 (2021)
Fabiola Puentes, Pascal Benkert, Sandra Amor, Jens Kuhle, Gavin Giovannoni
Antibodies to neurofilament light as potential biomarkers in multiple sclerosis. BMJ neurology open 3 (2) (2021)
Kimberley Allen-Philbey, Stefania De Trane, Zhifeng Mao, Cesar Álvarez-González, Joela Mathews, Amy MacDougall, Andrea Stennett, Xia Zhou, Ozlem Yildiz, Ashok Adams, Lucia Bianchi, Camilla Blain, Christine Chapman, Karen Chung, Cris S Constantinescu, Catherine Dalton, Rachel A Farrell, Leonora Fisniku, Helen Ford, Bruno Gran, Jeremy Hobart, Zhaleh Khaleeli, Miriam Mattoscio, Sue Pavitt, Owen Pearson, Luca Peruzzotti-Jametti, Antonio Scalfari, Basil Sharrack, Eli Silber, Emma C Tallantyre, Stewart Webb, Benjamin P Turner, Monica Marta, Sharmilee Gnanapavan, Gunnar Juliusson, Gavin Giovannoni, David Baker, Klaus Schmierer
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Therapeutic advances in neurological disorders 14 (2021)
Jerold Chun, Gavin Giovannoni, Samuel F Hunter
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects. Drugs 81 (2) (2021)
Tjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, Virender Bhan, Carrie M Hersh, Olaf Hoffmann, Celia Oreja-Guevara, Rene R Robles-Cedeño, Maria Trojano, Patrick Vermersch, Maria Pamela Dobay, Mudeer Khwaja, Bianca Stadler, Benedict Rauser, Thomas Hach, Daniela Piani-Meier, Jason Burton
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey. Journal of medical Internet research 23 (10) (2021)
Nicholas G Cunniffe, Khue Anh Vuong, Debbie Ainslie, David Baker, Judy Beveridge, Sorrel Bickley, Patrick Camilleri, Matthew Craner, Denise Fitzgerald, Alerie G de la Fuente, Gavin Giovannoni, Emma Gray, Lorraine Hazlehurst, Raj Kapoor, Ranjit Kaur, David Kozlowski, Brooke Lumicisi, Don Mahad, Björn Neumann, Alan Palmer, Luca Peruzzotti-Jametti, Stefano Pluchino, Jennifer Robertson, Alan Rothaul, Lyndsey Shellard, Kenneth J Smith, Alastair Wilkins, Anna Williams, Alasdair Coles
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry 92 (3) (2020)
Saúl Reyes, Mary Ramsay, Shamez Ladhani, Gayatri Amirthalingam, Neena Singh, Carlos Cores, Joela Mathews, Jonathan Lambourne, Monica Marta, Benjamin Turner, Sharmilee Gnanapavan, Chu-Yueh Guo, Klaus Schmierer, Gavin Giovannoni
Protecting people with multiple sclerosis through vaccination. Practical neurology 20 (6) (2020)
Saúl Reyes, Sebastian Suarez, Kimberley Allen-Philbey, Alison Thomson, Gavin Giovannoni
The impact of social capital on patients with multiple sclerosis. Acta neurologica Scandinavica 142 (1) (2020)
Johan Aarum, Claudia P Cabrera, Tania A Jones, Shiron Rajendran, Rocco Adiutori, Gavin Giovannoni, Michael R Barnes, Andrea Malaspina, Denise Sheer
Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates. EMBO reports 21 (10) (2020)
Chu-Yueh Guo, Pooja Dassan, Megan Roberts, Gavin Giovannoni, Catherine Nelson-Piercy, Peter A Brex
UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines. Practical neurology 19 (2) (2019)
Gavin Giovannoni
Cladribine to Treat Relapsing Forms of Multiple Sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 14 (4) (2018)
Alison Thomson, Dominika Raciborska, David Baker, Gavin Giovannoni
How to start a blog. Practical neurology 17 (3) (2017)
Ruth Dobson, Hannah R Cock, Peter Brex, Gavin Giovannoni
Vitamin D supplementation. Practical neurology 18 (1) (2017)